Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America.
PLoS One. 2013 May 1;8(5):e63397. doi: 10.1371/journal.pone.0063397. Print 2013.
Multidrug-resistant (MDR) Gram-negative bacteria have emerged as a serious threat to human and animal health. Bdellovibrio spp. and Micavibrio spp. are Gram-negative bacteria that prey on other Gram-negative bacteria. In this study, the ability of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus to prey on MDR Gram-negative clinical strains was examined. Although the potential use of predatory bacteria to attack MDR pathogens has been suggested, the data supporting these claims is lacking. By conducting predation experiments we have established that predatory bacteria have the capacity to attack clinical strains of a variety of ß-lactamase-producing, MDR Gram-negative bacteria. Our observations indicate that predatory bacteria maintained their ability to prey on MDR bacteria regardless of their antimicrobial resistance, hence, might be used as therapeutic agents where other antimicrobial drugs fail.
多重耐药(MDR)革兰氏阴性菌已成为人类和动物健康的严重威胁。蛭弧菌属和噬纡菌属是捕食其他革兰氏阴性菌的革兰氏阴性菌。在这项研究中,检查了蛭弧菌和噬绿菌捕食 MDR 革兰氏阴性临床菌株的能力。尽管已经提出了利用捕食性细菌攻击多重耐药病原体的潜在用途,但缺乏支持这些说法的数据。通过进行捕食实验,我们已经确定捕食性细菌有能力攻击各种产生β-内酰胺酶的、多重耐药的革兰氏阴性临床菌株。我们的观察表明,捕食性细菌保持了捕食 MDR 细菌的能力,而不管它们的抗微生物耐药性如何,因此,在其他抗菌药物失败的情况下,可能被用作治疗剂。